Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib Cream in Alopecia Areata
NCT02553330Phase 2Terminated
- Sponsor
- Incyte
- Start
- Nov 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruxolitinib cream in alopecia areata, sponsored by Incyte. Started Nov 2015; status: terminated.
02
Drugs
ruxolitinib cream
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02553330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02553330.